Nimish Shah's most recent trade in Korsana Biosciences Inc. was a trade of 48,445 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Korsana Biosciences Inc | Nimish Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 48,445 | 48,445 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc | Nimish Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 7,657 | 7,657 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc | Nimish Shah | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Oct 2025 | 365,853 | 365,853 | - | - | Pre-Funded Warrants (Right to Buy) | |
| Apogee Therapeutics Inc | Nimish Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 14,461 | 14,461 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc | Nimish Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 10,370 | 10,370 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc | Nimish Shah | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 13 Jul 2023 | 1,750,000 | 1,750,000 | - | 17 | 29,750,000 | Common Stock |
| Apogee Therapeutics Inc | Nimish Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 47,758 | 47,758 | - | - | Stock Option (Right to Buy) |